NEXT WEEK: IIRUSA’s ePharma Summit, Philadelphia, PA. I’ll be there, reporting live via social media. You?
TODAY’S NEWS
Untreated, minor depression may well lead to major depression.
Coming: “artificial pancreas” technology for treatment of Type 1 diabetes? Pretty cool!
Good to know – Astelin is not indicated as a cure for house cleaning!
How a pharma company can get skewered by analysts for fudging numbers.
RECOMMENDED
Compliance training – Sales reps, internal folks – everyone needs some level of compliance training. And Impactiviti’s business partners have the solutions you need. Contact us (stevew at impactiviti dot com, or phone at 973-947-7429) for recommendations of providers.
PLUS
Virtual worlds – are they useful for business, or just so much shiny noise? What are your thoughts? And, from Forbes, 10 Misleading Drug Ads.
JUST FOR FUN
———-
Subscribe to the Impactiviti blog via e-mail (which will bring you Impactiviti Daily – a brief of the day’s top pharma news)
Sign up for the Impactiviti Connection twice-monthly e-newsletter (see sample)
Connect with Steve Woodruff
Leave a Reply